Search alternatives:
large decrease » marked decrease (Expand Search), large degree (Expand Search)
via large » a large (Expand Search)
b larger » _ larger (Expand Search), _ large (Expand Search), a large (Expand Search)
b large » _ large (Expand Search), a large (Expand Search), _ larger (Expand Search)
i large » _ large (Expand Search), a large (Expand Search), i larvae (Expand Search)
increases » increased (Expand Search), increase (Expand Search)
large decrease » marked decrease (Expand Search), large degree (Expand Search)
via large » a large (Expand Search)
b larger » _ larger (Expand Search), _ large (Expand Search), a large (Expand Search)
b large » _ large (Expand Search), a large (Expand Search), _ larger (Expand Search)
i large » _ large (Expand Search), a large (Expand Search), i larvae (Expand Search)
increases » increased (Expand Search), increase (Expand Search)
-
141
-
142
-
143
DataSheet_1_Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma.xlsx
Published 2021“…The genes most frequently altered (> 20%) were (in decreasing order of frequency) CDKN2A, PIM1, CD79B, TP53, MYD88, MYC, BTG2, BTG1, CDKN2B, DTX1, CD58, ETV6, and IRF4. …”
-
144
-
145
Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.
Published 2025Subjects: -
146
-
147
-
148
-
149
-
150
-
151
Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.
Published 2025Subjects: -
152
Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.
Published 2025Subjects: -
153
-
154
A model for elucidating the transovarial transmission of <i>N</i>. <i>bombycis</i>.
Published 2023Subjects: -
155
-
156
-
157
-
158
<i>N</i>. <i>bombycis</i> coated with BmVg in hemolymph and ovariole sheath.
Published 2023Subjects: -
159
TEM demonstrated the infection of follicle and nurse cells by <i>N</i>. <i>bombycis</i>.
Published 2023Subjects: -
160
<i>N</i>. <i>bombycis</i> infected oocyte from the follicle and nurse cells.
Published 2023Subjects: